![Jon Jessmer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jon Jessmer
Operationeel Directeur bij Curapath & Expansion of Drug Delivery Capabilities & Services
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Julio Enrique Serrano Noguès | M | - |
Curapath & Expansion of Drug Delivery Capabilities & Services
![]() Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | - |
Jose Conejos | M | - |
Curapath & Expansion of Drug Delivery Capabilities & Services
![]() Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | - |
Philippe Clavel | M | 51 |
Curapath & Expansion of Drug Delivery Capabilities & Services
![]() Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Spanje | 3 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Jon Jessmer
- Persoonlijk netwerk